Trial intelligence / Profile preview

NatrOVA vs NIX in Pediculosis Capitis

NCT00545753Phase 3Completed

Sponsor
ParaPRO
Start
Sep 2007
Primary completion
Mar 2008
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 3 trial of spinosad in pediculosis capitis, sponsored by ParaPRO. Started Sep 2007; status: completed.

02

Drugs

spinosad
03

Conditions

pediculosis capitis

Beyond the preview

Go deeper on NCT00545753.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00545753.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call